tetraiodothyroacetic acid has been researched along with resveratrol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsequell, G; Blasi, D; Bosch, L; Centeno, NB; Cotrina, EY; Pinto, M; Planas, A; Quintana, J; Valencia, G; Vilà, M | 1 |
| Davis, FB; Davis, PJ; Lin, HY; Shih, A | 1 |
| Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B | 1 |
| Bennett, JA; Changou, CA; Chen, YR; Chin, YT; Davis, PJ; Fu, E; Ho, Y; Incerpi, S; Li, WS; Lin, CY; Lin, HY; Liu, LF; Mousa, SA; Nana, AW; Pedersen, JZ; Shih, YJ; Whang-Peng, J | 1 |
4 other study(ies) available for tetraiodothyroacetic acid and resveratrol
| Article | Year |
|---|---|
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Topics: Diflunisal; Flufenamic Acid; Halogenation; Humans; Kinetics; Ligands; Models, Molecular; Prealbumin; Protein Multimerization; Protein Structure, Secondary; Structure-Activity Relationship | 2013 |
Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.
Topics: 3T3 Cells; Animals; Cell Fractionation; Cell Line; Cell Nucleus; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nuclear Proteins; Oligonucleotides, Antisense; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-jun; Receptors, Thyroid Hormone; Resveratrol; Serine; Stilbenes; Thyroxine; Transfection; Triiodothyronine; Tumor Suppressor Protein p53 | 2001 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine | 2011 |
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Mice, Nude; Resveratrol; Thyroxine | 2018 |